BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24/02/2022

FDA Announces Virtual Public Meeting on Biosimilar User Fee Act Program

The FDA is hosting a virtual public meeting to discuss the final assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act and invite public comments on the topics.

Source: Federal Register — Food and Drug AdministrationOpen original release →